To hear about similar clinical trials, please enter your email below
Trial Title:
Unveiling Patient Experiences in Testicular Cancer Clinical Trials
NCT ID:
NCT05928377
Condition:
Testicular Cancer
Conditions: Official terms:
Testicular Neoplasms
Conditions: Keywords:
testicular cancer
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Clinical research participation has historically been heavily biased toward specific
demographics.
Several people will be invited to enroll in this study so that it may collect a variety
of data about testicular cancer clinical study experiences and identify barriers to
participation as well as the causes of participants' failure or withdrawal.
People with testicular cancer who are invited to take part in medical research will
benefit from the analysis of the data.
Criteria for eligibility:
Study pop:
Testicular cancer patients who are actively considering enrolling in a clinical trial for
the said condition, but have not yet completed enrollment and randomization phases.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Aged ≥ 18 years old and ability to provide written informed consent obtained prior
to participation in the study and any related procedures being performed
- Diagnosis of testicular cancer
- No prior treatment for testicular cancer
Exclusion Criteria:
- Has known psychiatric or substance abuse disorders that would interfere with
cooperation with the requirements of the trial
- Enrolled in another research study
- Inability to provide written informed consent
Gender:
Male
Gender based:
Yes
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Start date:
July 2024
Completion date:
July 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05928377
